Xvivo Perfusion AB (publ) carries a market capitalization of 8.95B, placing it among publicly traded companies globally.
| Market Cap | 8.95B |
| Enterprise Value | N/A |
Xvivo Perfusion AB (publ)'s stock has declined approximately -2.2678% over the past 52 weeks. The 50-day moving average sits at 291.55, while the 200-day moving average is 282.98.
| Beta (5Y) | N/A |
| 52-Week Price Change | -2.2678% |
| 50-Day Moving Average | 291.55 |
| 200-Day Moving Average | 282.98 |
| Average Volume (20 Days) | N/A |